Literature DB >> 33662101

Approaches for Optimal Use of Different COVID-19 Vaccines: Issues of Viral Variants and Vaccine Efficacy.

John P Moore1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33662101     DOI： 10.1001/jama.2021.3465

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  22 in total

Review 1.  Workplace interventions to reduce the risk of SARS-CoV-2 infection outside of healthcare settings.

Authors:  Ana Beatriz Pizarro; Emma Persad; Solange Durao; Barbara Nussbaumer-Streit; Jean S Engela-Volker; Damien McElvenny; Sarah Rhodes; Katie Stocking; Tony Fletcher; Craig Martin; Kukuh Noertjojo; Olivia Sampson; Jos H Verbeek; Karsten Juhl Jørgensen; Matteo Bruschettini
Journal:  Cochrane Database Syst Rev       Date:  2022-05-06

Review 2.  [The corona pandemic and multiple sclerosis: vaccinations and their implications for patients-Part 2: vaccine technologies].

Authors:  Tobias Monschein; Tobias Zrzavy; Micha Löbermann; Alexander Winkelmann; Thomas Berger; Paulus Rommer; Hans-Peter Hartung; Uwe K Zettl
Journal:  Nervenarzt       Date:  2021-07-07       Impact factor: 1.297

3.  Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy.

Authors:  Patrizio Colaneri; Raffaele Bruno; Giulia Giordano; Marta Colaneri; Alessandro Di Filippo; Franco Blanchini; Paolo Bolzern; Giuseppe De Nicolao; Paolo Sacchi
Journal:  Nat Med       Date:  2021-04-16       Impact factor: 53.440

Review 4.  The ins and outs of SARS-CoV-2 variants of concern (VOCs).

Authors:  Mostafa Salehi-Vaziri; Mehdi Fazlalipour; Seyed Mahmood Seyed Khorrami; Kayhan Azadmanesh; Mohammad Hassan Pouriayevali; Tahmineh Jalali; Zabihollah Shoja; Ali Maleki
Journal:  Arch Virol       Date:  2022-01-28       Impact factor: 2.685

5.  Association between county-level risk groups and COVID-19 outcomes in the United States: a socioecological study.

Authors:  Sadiya S Khan; Amy E Krefman; Megan E McCabe; Lucia C Petito; Xiaoyun Yang; Kiarri N Kershaw; Lindsay R Pool; Norrina B Allen
Journal:  BMC Public Health       Date:  2022-01-13       Impact factor: 3.295

6.  Heterologous vaccination interventions to reduce pandemic morbidity and mortality: Modeling the US winter 2020 COVID-19 wave.

Authors:  Nathaniel Hupert; Daniela Marín-Hernández; Bo Gao; Ricardo Águas; Douglas F Nixon
Journal:  Proc Natl Acad Sci U S A       Date:  2022-01-18       Impact factor: 11.205

Review 7.  Exploring the COVID-19 vaccine candidates against SARS-CoV-2 and its variants: where do we stand and where do we go?

Authors:  Gaurav Joshi; Pobitra Borah; Shweta Thakur; Praveen Sharma; Ramarao Poduri
Journal:  Hum Vaccin Immunother       Date:  2021-12-02       Impact factor: 3.452

8.  [Possible effect of the "original antigenic sin" in vaccination against new variants of SARS-CoV-2].

Authors:  J Reina
Journal:  Rev Clin Esp       Date:  2021-06-05       Impact factor: 1.556

Review 9.  Airborne Coronaviruses: Observations from Veterinary Experience.

Authors:  Paolo Pozzi; Alessio Soggiu; Luigi Bonizzi; Nati Elkin; Alfonso Zecconi
Journal:  Pathogens       Date:  2021-05-19

Review 10.  Potency of BNT162b2 and mRNA-1273 vaccine-induced neutralizing antibodies against severe acute respiratory syndrome-CoV-2 variants of concern: A systematic review of in vitro studies.

Authors:  Maryam Noori; Seyed Aria Nejadghaderi; Shahnam Arshi; Kristin Carson-Chahhoud; Khalil Ansarin; Ali-Asghar Kolahi; Saeid Safiri
Journal:  Rev Med Virol       Date:  2021-07-19       Impact factor: 11.043
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.